US Patent

US8883838 — Pharmaceutical cream compositions and methods of use

Formulation · Assigned to Allergan Inc · Expires 2031-12-01 · 6y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical cream compositions containing oxymetazoline hydrochloride for treating rosacea and other skin disorders.

USPTO Abstract

The present invention provides pharmaceutical cream compositions comprising oxymetazoline and methods for treating rosacea and other skin disorders as described herein using the above cream compositions.

Drugs covered by this patent

oxymetazoline-hydrochloride (OXYMETAZOLINE HYDROCHLORIDE)

Patent Metadata

Patent number: US8883838
Jurisdiction: US
Classification: Formulation
Expires: 2031-12-01
Drug substance claim: No
Drug product claim: Yes
Assignee: Allergan Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.